NCT00092131View on ClinicalTrials.gov

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Asthma, Exercise-Induced
Interventions
DRUG

Comparator: Montelukast

Montelukast 10 mg tablet administered orally as a single witnessed dose before exercise challenge

DRUG

Comparator: Placebo

Placebo tablet administered orally as a single witnessed dose before exercise challenge

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092131 - Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) | Biotech Hunter | Biotech Hunter